Patients whose tumour had an E-cadherin expression low-to-nil (score 0 to 1+) showed a tendency toward an increased risk of failure vs patients with intermediate E-cadherin expression (score 2+ HR=1.71; CI=0.72–4.06). The gene discussed is CDH1; the disease is neoplasm.